Loading organizations...
Established in 2000, Zero2IPO Group has positioned itself as a leading venture capital and private equity service provider and a recognized investment firm in China. The organization offers an integrated suite of services designed to support the private equity industry.
Key people at Zero2IPO.
Yes, Zero2IPO Ventures is the venture capital arm of Zero2IPO Group, with investments spanning sectors such as healthcare, security, e-commerce, oncology, life sciences, mobile, and clean technology.
Zero2IPO Group contributes through its research arm, Zero2IPO Research, which analyzes investment trends, and by releasing annual rankings for China's venture capital and private equity industry.
Yes, Zero2IPO Ventures is the venture capital arm of Zero2IPO Group, with investments spanning sectors such as healthcare, security, e-commerce, oncology, life sciences, mobile, and clean technology.
Zero2IPO Group contributes through its research arm, Zero2IPO Research, which analyzes investment trends, and by releasing annual rankings for China's venture capital and private equity industry.
Zero2IPO Group is publicly listed as a Chinese media company, with its core focus centered on providing services to firms within the venture capital and private equity sectors. This strategic positioning allows it to cater to the specific needs of the equity investment landscape.
The firm's investment activities are notably channeled through Zero2IPO Ventures, its venture capital arm. This division actively invests across a diverse range of sectors, including healthcare, security, e-commerce, oncology, life sciences, mobile technology, and clean energy initiatives.
Beyond direct investment, Zero2IPO Group contributes significantly to market intelligence through its research arm, Zero2IPO Research. This unit conducts analyses on investment trends, such as the evolving proportion of investment by state-owned institutions within China's equity market.
Zero2IPO Group further solidifies its role in the ecosystem by annually releasing comprehensive rankings for China's venture capital and private equity industry. These rankings provide valuable benchmarks and insights for market participants.
Zero2IPO has 4 tracked investments across 4 companies. The latest tracked deal is Series A in Ruidong New Energy in February 2026.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Feb 6, 2026 | Ruidong New Energy | Series A | Zero2IPO | Fuzhong Capital, Huaian Haoun Jiansu Industrial Investment Fund |
| Aug 25, 2022 | HanchorBio | $20.0M Series A | Sino Biopharmaceutical | — |
| Dec 29, 2017 | Beijing Aladdin Future Technology | $4.6M Pre-Series A | Ameba Capital | Sinovation Ventures |
| Mar 17, 2010 | Origene Technologies | $16.0M Series B | IDG Accel, SBI Investment, Zero2IPO | Morningside, President International Development Corporation |
Key people at Zero2IPO.
